InspireMD, Inc. NSPR
$0.98
+16.94%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $3.00
- Implied Upside
- +205.4%
- Price Target Range
- $3.00 – $3.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-05 | Piper SandlerAdam Maeder |
Reiterates | Overweight | $4 → $3 |
| 2025-05-12 | Piper SandlerAdam Maeder |
Maintains | Overweight | $5 → $4 |
| 2024-12-11 | Lake StreetFrank Takkinen |
Initiates coverage on | Buy | $5 |
| 2024-09-17 | Piper SandlerAdam Maeder |
Reiterates | Overweight | $5 |
| 2023-11-02 | Piper SandlerAdam Maeder |
Maintains | Overweight | $4 → $5 |
| 2023-06-12 | Piper SandlerAdam Maeder |
Initiates coverage on | Overweight | $3 |
| 2023-05-17 | National Alliance SecuritiesBen Haynor |
Maintains | Buy | $5 → $5 |
| 2023-03-31 | Alliance Global PartnersBen Haynor |
Maintains | Buy | $6 → $5 |
| 2020-10-16 | Alliance Global PartnersBen Haynor |
Initiates coverage on | Buy | $11 |
| 2020-03-11 | HC Wainwright & Co.Vernon Bernardino |
Reiterates | Buy | $75 → $30 |
| 2016-03-29 | Rodman & Renshaw |
Maintains | Buy | $4 → $3 |
| 2016-01-07 | HC Wainwright & Co. |
Initiates coverage on | Buy | $4 |
| 2015-03-13 | Oppenheimer |
Downgrades | Outperform → Perform | — |
| 2013-11-26 | Oppenheimer |
Initiates coverage on | Outperform | $6 |
| 2013-05-08 | Cowen & Co. |
Initiates coverage on | Outperform | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.98
- Market Cap
- $46.01 million
- 52-Week Range
- $0.63 – $2.93
- Average Volume
- 71K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.